Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
Conditions
Chronic Liver Disease. - Hepatocellular Carcinoma. - Liver Fibrosis.
Conditions: official terms
Carcinoma, Hepatocellular - Liver Diseases
Conditions: Keywords
Liver disease, Multi Spectral CT
Study Type
Interventional
Study Phase
N/A
Study Design
Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
Intervention
Name: Multispectral CT of the liver
Type: Device
Overall Status
Not yet recruiting
Summary
The purpose of this study is to improve stratification of patients with chronic liver disease through non-invasive detection and characterization of small liver tumors and liver fibrosis by means of using multi spectral CT.
Detailed Description
This is a type IV phase study, in which an FDA approved imaging device currently used for studying chronic liver disease has not yet been validated.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- adult patient undergoing CT scan for/suspicion of hepatocellular carcinoma.

- Patients should be scheduled for/or should have obtained a multiphasic MRI of the liver.

Exclusion Criteria:

- patients < 18 years old.

- history of allergy to intravenous contrast.

- patients at risk for contrast-induced-nephropathy,

- pregnant patients.
Location
Massachusetts General Hospital,
Boston, Massachusetts, United States
Status: Not yet recruiting
Contact: Jorge M Fuentes Orrego, MD - 617-726-8386 - jmfuentes@partners.org
Start Date
November 2013
Completion Date
May 2015
Sponsors
Massachusetts General Hospital
Source
Massachusetts General Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page